文献速递其他结缔组织病

胸壁肌肉萎缩是系统性硬化相关间质性肺病FVC下降的贡献因素

Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

这项单中心回顾性研究纳入36例系统性硬化相关间质性肺病(SSc-ILD)患者,间隔1-3年同步进行肺功能检查与胸部高分辨率CT,评估用力肺活量(FVC)、ILD范围和胸壁肌肉面积的变化及相关性。结果显示胸壁肌肉面积随时间显著下降(P=0.0008),FVC变化与ILD范围变化负相关(r=-0.48,P=0.003)、与胸壁肌肉面积变化正相关(r=0.53,P=0.001),多因素分析显示两者均为FVC下降的独立贡献因素。

要点

  • SSc-ILD患者FVC下降不仅源于ILD进展,也源于辅助呼吸肌萎缩。
  • 胸壁肌肉面积随时间显著下降(P=0.0008)。
  • 解读SSc-ILD患者FVC变化时需考虑胸壁肌肉萎缩的影响。

核心结论

  • 在SSc-ILD患者中,FVC下降不仅归因于ILD进展,也归因于辅助呼吸肌萎缩。

研究设计与样本

  • 单中心回顾性研究纳入36例SSc-ILD患者,间隔1-3年同步进行肺功能检查与胸部高分辨率CT(HRCT)。
  • 由两名对患者信息不知情的独立评估者评估CT图像上ILD总范围及第9胸椎水平胸壁肌肉面积。

主要发现

  • FVC和ILD总范围的间隔变化在患者间存在差异,而胸壁肌肉面积随时间显著下降(P=0.0008)。
  • FVC变化与ILD范围变化负相关(r=-0.48,P=0.003),与胸壁肌肉面积变化正相关(r=0.53,P=0.001)。
  • 多因素分析显示ILD总范围变化和胸壁肌肉面积变化是FVC下降的独立贡献因素。

临床怎么用

  • 解读SSc-ILD患者FVC变化时,应关注胸壁肌肉萎缩对FVC下降的潜在贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the potential contribution of accessory respiratory muscle atrophy to the decline of forced vital capacity (FVC) in patients with SSc-associated interstitial lung disease (ILD). METHODS: This single-centre, retrospective study enrolled 36 patients with SSc-ILD who underwent serial pulmonary function tests and chest high-resolution CT (HRCT) simultaneously at an interval of 1-3 years. The total extent of ILD and chest wall muscle area at the level of the ninth thoracic vertebra on CT images were evaluated by two independent evaluators blinded to the patient information. Changes in the FVC, ILD extent, and chest wall muscle area between the two measurements were assessed in terms of their correlations. Multiple regression analysis was conducted to identify the independent contributors to FVC decline. RESULTS: Interval changes in FVC and total ILD extent were variable among patients, whereas chest wall muscle area decreased significantly with time (P=0.0008). The FVC change was negatively correlated with the change in ILD extent (r=-0.48, P=0.003) and was positively correlated with the change in the chest wall muscle area (r = 0.53, P=0.001). Multivariate analysis revealed that changes in total ILD extent and chest wall muscle area were independent contributors to FVC decline. CONCLUSION: In patients with SSc-ILD, FVC decline is attributable not only to the progression of ILD but also to the atrophy of accessory respiratory muscles. Our findings call attention to the interpretation of FVC changes in patients with SSc-ILD.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Nawata T, Shirai Y, Suzuki M, et al. Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2021. PMID: 32699895. doi:10.1093/rheumatology/keaa322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。